Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
基本信息
- 批准号:10620614
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdministratorAdvisory CommitteesAffectAntibiotic TherapyAntibioticsAntimicrobial ResistanceAreaCOVID-19CaringCellulitisCessation of lifeClinicalClinical PharmacistsClinical Practice GuidelineClinical effectivenessCollaborationsCommunicable DiseasesCommunity HealthcareComplexConsultationsCost AnalysisDataDevelopmentDissemination and ImplementationEffectivenessEvidence based interventionFeedbackGoalsGuidelinesHealthHealth ServicesHealth Services AccessibilityHealthcareHealthcare SystemsImprove AccessIndividualInfectionInfection ControlInterventionInterviewLengthLong-Term CareMapsMeasuresMedical centerMentorsMethodologyMethodsModelingModificationNursesOutcomeOutcome MeasureOutpatientsParticipantPatient CarePerceptionPharmacistsPhysiciansPilot ProjectsPneumoniaPolicy MakerPreventionProcessProviderQuality of CareRandomizedRecommendationReportingResourcesRisk FactorsRoleRuralRural HealthServicesSiteSpecialistStructureSystemTeleconferencesTestingTrainingUnited States Department of Veterans AffairsUrinary tract infectionVeteransWorkantimicrobialcare outcomescare providersclinical carecombatdesigneffectiveness/implementation designevidence baseevidence based guidelinesexperiencefeasibility testinggeographically distantglobal healthhealthcare-associated infectionsimplementation barriersimplementation costimplementation evaluationimprovedinnovationinterestmedical specialtiesmembermilitary veteranmultidisciplinarynovel coronavirusnovel strategiesoperationpathogenpatient safetypatient subsetspeerpharmacy benefitpreventprimary outcomeprogramssecondary outcometelehealthvideoconference
项目摘要
Background: Antimicrobial stewardship guidelines call for a multidisciplinary team with an infectious disease
(ID) physician and ID-trained clinical pharmacist as core members. Unfortunately, there are insufficient ID-
trained specialists to staff on-site antimicrobial stewardship programs throughout VA.
Significance: This proposal is highly significant for Veterans and the goals of VA. Veterans experience many
of the risk factors associated with development of antimicrobial resistant and healthcare-associated infections.
The unprecedented effects of the novel Coronavirus disease 2019 (COVID-19) on the health of our Veterans
and on our entire healthcare system makes the demand for ID expertise even more apparent, especially in
long-term care. Also, this study directly addresses the VA MISSION ACT to improve access to care,
timeliness and quality of care, using telehealth services. Finally, this project is aligned with the priorities of
our operation partners: VA Antimicrobial Stewardship Taskforce (ASTF), the VA National Infectious Disease
Service (NIDS), VA Pharmacy Benefits Management (PBM) Services, and the Office of Rural Health.
Innovation and Impact: The design is innovative because we will systematically test and assess
implementation barriers to telehealth for antimicrobial stewardship, a novel approach that has not been
implemented in VA facilities, other than in our previous pilot study. Further, the Antibiotic Use Reports (AURs)
are an innovative adaptation of peer-comparison, an antibiotic stewardship strategy successful in outpatient
settings. This project will provide findings for a scalable model that could be deployed nationally to all
applicable VAMCs, continuing the role of VHA as a leader in implementing large-scale interventions focused
on prevention and management of ID and stewardship.
Specific Aims: Our goal is to implement a multidisciplinary videoconference antimicrobial stewardship team
(VAST) in VAMCs using SCAN-ECHO. Our central hypothesis is that feedback reports that quantify facility-
level antibiotic use will enhance the efficacy of VASTs to support antimicrobial stewardship. We propose a
Type 2 hybrid effectiveness-implementation design, comparing clinical effectiveness in sites that implement the
VAST alone (VAST-) to sites that implement the VAST augmented by facility-level Antibiotic Use Reports
(VAST+). Aims are: 1) Identify and test effective strategies for implementing the VAST; 2) Determine the
influence of the VAST overall and VAST+ on the care of Veterans with suspected infections; 3) Determine the
influence of the VAST overall and VAST+ on antibiotic use at each VAMC.
Methodology: We will randomize rural VAMCs that do not have ID-trained professionals on staff to implement
the VAST alone (VAST-) versus VAST + antibiotic use feedback (VAST+). Aim 1: We will assess modification
and adaptations at the intervention sites and by the infectious disease experts. Methods will include process
maps and semi-structured interviews to gather qualitative data about what key VAST members perceive as
facilitators, barriers and burden to VAST implementation. We will also evaluate costs of implementation. Aim 2:
We will evaluate the Veteran population served, clinical activities, and user perceptions of the VAST. We will
assess the concordance of clinical care with recommendations from evidence-based clinical practice
guidelines. VAST members’ perceptions of the quality and timeliness of care will be evaluated. Aim 3: The
primary outcome measure will be overall rates of antibiotic use. Secondary outcomes will be changes in the
rates of broad-spectrum antibiotic use, antibiotic starts, and length of antibiotic therapy.
Next steps/Implementation: Testing effective implementation of the VAST at additional VAMCs is an
important step toward augmenting antimicrobial stewardship in both acute- and long-term care settings. In
collaboration with VA clinical operation partners, outcomes from this trial will be used to roll-out an
implementation playbook to be used by other VAMCs, as well as non-VA settings.
背景:抗菌药物管理指南呼吁成立一个患有传染病的多学科团队
(ID)作为核心成员的内科医生和经过ID培训的临床药剂师。不幸的是,没有足够的身份证-
训练有素的专家为整个退伍军人管理局的现场抗菌管理计划提供工作人员。
意义:这项建议对退伍军人和退伍军人管理局的目标具有非常重要的意义。退伍军人经历了许多
与抗菌素耐药性和医疗保健相关感染的发展相关的风险因素。
新型冠状病毒病2019(新冠肺炎)对退伍军人健康的前所未有的影响
对我们整个医疗系统的需求使得对身份识别专业知识的需求更加明显,特别是在
长期护理。此外,这项研究直接涉及退伍军人事务部的任务法案,以改善获得护理的机会,
使用远程医疗服务的及时性和护理质量。最后,该项目与以下优先事项保持一致
我们的行动伙伴:退伍军人管理局抗菌特别工作组(ASTF),退伍军人管理局国家传染病
国家卫生服务(NDS)、退伍军人管理局药房福利管理(PBM)服务和农村卫生办公室。
创新和影响:设计是创新的,因为我们将系统地测试和评估
抗菌药物管理远程保健的实施障碍,这是一种尚未
在退伍军人管理局设施中实施,而不是在我们之前的试点研究中。此外,抗生素使用报告(AURS)
是对同行比较的创新适应,是在门诊患者中成功的抗生素管理策略
设置。该项目将为可扩展的模型提供发现,该模型可以在全国范围内部署到所有
适用的VAMC,继续发挥VHA在实施有重点的大规模干预方面的领导作用
关于ID和管家的预防和管理。
具体目标:我们的目标是实施一个多学科视频会议抗菌管理团队
(VASS)在VAMCs中使用扫描回波。我们的中心假设是量化设施的反馈报告-
抗生素的水平使用将提高VASS的效力,以支持抗菌药物的管理。我们提出了一个
类型2混合有效性-实施设计,比较实施
Vavar Alone(Vavar)--到实施由设备级抗生素使用报告增强的大量报告的网站
(大量)。目标是:1)确定和测试实施VASS的有效战略;2)确定
广大群众对疑似感染退伍军人护理工作的影响;3)确定
广泛性、全局性和广泛性+对每个VAMC使用抗生素的影响。
方法:我们将对没有经过ID培训的专业人员的农村VAMC进行随机化实施
大量单独(大量-)与大量+抗生素使用反馈(大量+)。目标1:我们将评估修改
以及干预地点和传染病专家的适应情况。方法将包括流程
地图和半结构化访谈,以收集关于关键的广大成员所感知的定性数据
推动者、障碍和负担阻碍了广泛的执行。我们还将评估实施成本。目标2:
我们将评估所服务的退伍军人群体、临床活动和用户对海量的看法。我们会
评估临床护理与循证临床实践建议的一致性
指导方针。将对广大成员对护理质量和及时性的看法进行评估。目标3:
主要结果衡量标准将是抗生素的总体使用率。次要结果将是
广谱抗生素使用率、抗生素开始使用和抗生素治疗持续时间。
下一步/实施:在更多的VAMC测试VAST的有效实施是一个
在急性和长期护理环境中加强抗菌药物管理的重要一步。在……里面
与退伍军人管理局临床运营合作伙伴合作,本次试验的结果将用于推出
供其他VAM以及非VA设置使用的实施攻略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLESNIKA T EVANS其他文献
CHARLESNIKA T EVANS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLESNIKA T EVANS', 18)}}的其他基金
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
- 批准号:
10672768 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
- 批准号:
10312278 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
10187395 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
10186505 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
9502631 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
9695865 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
9205309 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
10200821 - 财政年份:2016
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant














{{item.name}}会员




